1. HBW Insight
  2. >>Health
  3. >>Business

Aleve Challenge, New Study Catch Up To Advil 'Works Longer' Claim In NAD Review

 
• By Malcolm Spicer

Although 1993 studies to make Aleve available OTC didn't support claiming the naproxen oral analgesic lasted longer than ibuprofen-containing Advil, 2018 study Bayer submitted for National Advertising Division review shows Advil's efficacy doesn't exceed Aleve's. Report also says while Pfizer criticized inpatient methodology of Bayer's study, inpatient is industry standard method for pain medication trials.

Truth in Advertising Price Tag Honest Business 3d Render Illustration - Illustration

Evidence that supports making a drug available OTC in the US isn't the final word on marketing claims for the ingredient, a Council of Better Bureaus' industry self-regulation arm concluded in a review of Aleve marketer Bayer AG's challenge to Pfizer Inc.'s advertising for Advil.

A report published 10 September by the National Advertising Division of the council's BBB National Programs Inc. also states that...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Health

Orkla Relying On New Health Boss To Make Instant Impact

 
• By Tom Gallen

A rapid decline in performance has left Orkla Health's new CEO Mats Palmquist with a big job on his hands to turn around the business.

UK Government Recognizes Crucial Role Of OTCs In Medicines Supply Chain

 
• By David Ridley

Representing about a fifth of all licensed medicines in the UK, OTCs are considered a critical part of the country's health system, according to a recently published Department of Health and Social Care (DHSC) paper on UK medicines supply issues.

Combat Meth Act PSE Daily Purchase Limit Once Too High For States Now Embraced By Most

 
• By Malcolm Spicer

Limits so effective that states are relaxing restrictions they previously set exceeding the nationwide limit Congress imposed in Combat Meth Act in 2006 on the amount of PSE, as well as a second meth precursor, ephedrine, in OTC drugs consumers can purchase daily.